RxDoctor Payments Data

Ryan Pereira, DPM

Foot & Ankle Surgery · St Augustine, FLNPI 1033195979

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.0%), food and beverage and other — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Arteriocyte Medical Systems, Inc. at 48.5% of the total. Reporting peaked in 2019 at $28,484 and has fallen 85.4% since, to $4,152 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,332in general payments, 2019–2025

Across 389 payments — averaging $203.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arteriocyte Medical Systems, Inc.$38K
  • Angiodynamics, Inc.$17K
  • Integra Lifesciences Corporation$11K
  • Crossroads Extremity Systems, LLC$3K
  • Johnson & Johnson$1K
  • Stryker$1K
  • plus $8K from 54 others
$28,474in research payments, 2019–2025

Across 29 payments — averaging $981.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Axogen$28K

What the payments were for

  • Royalty or licence$2,7283%
  • Consulting fees$8,39011%
  • Speaking & faculty fees$36,50046%
  • Travel & lodging$2,4833%
  • Food & beverage$12,35516%
  • Education$7,2759%
  • Other$9,60012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,332 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$3,778,917
Medicare patients
502
Services billed
5,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin17$585
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$407
Gabapentin13$163
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$142
Methylprednisolone18$109
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$46

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in St Augustine

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →